Family Medicine · Glendale, CA
NPI
1720050032
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
134 N Glendale Ave
Glendale, CA, 91206
Phone (818) 662-8858
Groups this clinician bills Medicare through
Medicare paid, 2024
$871K
17,838 services
Medicare patients, 2024
365
Average age 77
Drug cost, 2024
$4.7M
26,399 prescriptions
Company payments, 2025
$3,498
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hrach Khudatyan was code 99213 (office e&m - established), 6,860 times for 358 patients. In total Hrach Khudatyan billed 17,838 services in 63 codes, and Medicare paid $871K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 6,860 | 358 | $76.21 | $523K |
| 17003 Destruction Skin Lesion | Office | 1,885 | 124 | $5.98 | $11K |
| 96372 Injection Administration | Office | 1,418 | 241 | $12.40 | $18K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 1,134 | 238 | $0.99 | $1,128 |
| 36415 Venipuncture Blood Collection | Office | 930 | 304 | $8.65 | $8,045 |
| 99212 Office E&M - Established | Office | 507 | 219 | $48.34 | $25K |
| 82962 Clinical Chemistry | Office | 382 | 108 | $3.21 | $1,226 |
| 99406 Behavioral Health Services | Office | 379 | 120 | $15.57 | $5,902 |
| 99214 Office E&M - Established | Office | 372 | 218 | $104.67 | $39K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 314 | 124 | $26.80 | $8,414 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 302 | 302 | $21.09 | $6,370 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 301 | 301 | $21.11 | $6,354 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 300 | 300 | $26.80 | $8,040 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 291 | 291 | $140.24 | $41K |
| 99497 Care Management/Coordination | Office | 274 | 274 | $67.68 | $19K |
By year: 2022 $711K for 15,711 services; 2023 $827K for 17,794 services; 2024 $871K for 17,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 930 | 304 | $8.65 | $8,045 |
| 82962 Clinical Chemistry | 382 | 108 | $3.21 | $1,226 |
| 83014 Clinical Chemistry | 14 | 13 | $7.70 | $108 |
Medicare prescription drug claims, 2024
In 2024, the drug Hrach Khudatyan prescribed most often to Medicare patients was Amlodipine Besylate, with 1,254 prescriptions and refills. In total Hrach Khudatyan wrote 26,399 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,254 | 1,514 | 150 | $1,379 |
| Atorvastatin Calcium Generic | 837 | 1,053 | 104 | $2,327 |
| Losartan Potassium Generic | 721 | 902 | 90 | $2,203 |
| Vascepa Icosapent Ethyl | 567 | 602 | 71 | $202K |
| Meclizine Hcl Generic | 551 | 578 | 70 | $3,482 |
| Rosuvastatin Calcium Generic | 543 | 673 | 69 | $1,942 |
| Omeprazole Generic | 523 | 573 | 58 | $1,470 |
| Metformin Hcl Generic | 497 | 617 | 62 | $1,116 |
| Levothyroxine Sodium Generic | 492 | 624 | 63 | $2,072 |
| Linzess Linaclotide | 484 | 537 | 54 | $277K |
| Donepezil Hcl Generic | 455 | 519 | 47 | $1,527 |
| Diclofenac Sodium Generic | 454 | 483 | 70 | $293K |
| Metoprolol Succinate Generic | 446 | 552 | 57 | $2,416 |
| Tamsulosin Hcl Generic | 444 | 524 | 56 | $1,837 |
| Ibuprofen Generic | 415 | 432 | 60 | $1,846 |
Brand drugs: 6,462 claims; generic drugs: 19,628 claims; opioid claims: 253.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hrach Khudatyan $3,498 ($3,498 in general payments such as food, travel and fees) from 29 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $445.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $445 |
| Abbvie Inc. ABBV | 14 | $321 |
| Ardelyx, Inc. ARDX | 10 | $241 |
| Amgen Inc. AMGN | 11 | $227 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $195 |
| Lundbeck LLC | 6 | $176 |
| Edwards Lifesciences Corporation EW | 1 | $157 |
| Esperion Therapeutics, Inc. ESPR | 7 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $143 |
| Lilly USA, LLC LLY | 6 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.